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Dear Editor,
The synovial gastrointestinal sarcoma is an extremely infre-
quent clinical entity that is usually diagnosed in esophagus dis-
tal and gastroesophagical union. We publish the first case of
synovial two-phase sarcoma with location duodenal described
in the world literature, with a typical inmunohistochemical
character.
Case report
It is a 70-year-old male who enters of urgencies for clinical
suggestive of acute pancreatitis. As precedents of interest the
patient is a smoker of approximately 20 cigarettes a day,
drinker of approximately 80 g of ethanol a day, suffers COPD
in treatment with inhalers, ulcus peptic without symptomatol-
ogy, biliary lithiasis and senile osteoporosis. In addition, al-
ready he had presented episodes of pancreatitis previous solved
by conservative treatment.
During his revenue, he presents clinic of debility, anorexia,
loss of weight, abdominal diffuse pain, jaundice and coluria
persistent. In the blood analyses he presented 18,850 leuko-
cytes (71% neutrophils), GGT of 512 U/ml, alkaline phos-
phatase of 818 U/ml, platelets of 763.000, bilirubin mg/dl (di-
rect of 3.18 mg/dl) and a Ca 19.9 of 49 U/ml. A CT was real-
ized, in which we appreciates acute nectrotizing pancreatitis
Baltasar grade E, by a tenuous captation in pancreatic tail that
provokes obstructive jaundice and affectation of vascular struc-
tures with splenic infarction (Fig. 1). With the diagnosis of
acute nectrotizing pancreatitis, we decided to realize surgical
intervention.
After subcostal laparotomy and exhibition of the pancreatic
cell, appears a duodenal tumor located in third portion that is
extirpated; in addition, there is carried out a cleanliness of the
pancreatic cell and cholecystectomy. Hospitable discharge is
decided to fourteen days of the intervention.
The anatomopathological analysis of the piece demonstrated
that it was a synovial two-phase sarcoma high degree of 9 cm,
Fig. 1. Transversal image of abdominal CT, showing duodenal neo-
plasm corresponding to sinovial sarcoma, as was verified by inmmuno-
histochemical analysis.
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with inmunohistochemical typical character and with the (X;
18) translocation expressed by means of the reclassification of
the gene 18q11.2 with presentation in 13 % of the tumour cells,
studied by means of FISH (Table I).
Discussion
The synovial sarcomas are tumors that habitually are diag-
nosed in extremities, principally on knees and in relation with
tendons and bursas. Recent finds in the molecular structure of
the synovial sarcomas, as the translocation t (X; 18), show the
presence of this type of tumors in unusual locations, as pleura,
lung and heart. The gastrointestinal tract, of which also there
are cases published with this type of sarcomas, continues being
an exceptional location, being the most of the published cases
synovial sarcomas of esophagus and stomach (1,2).
This type of tumors does not present a specific clinic, but de-
rived from the location of its growth. From the anatomopatho-
logical we can classify these tumors in two-phase and single-
phase depending on the morphologic presentation, already be
estromal and epitelial or only estromal.
The differential diagnosis of these injuries must be done by
other neoplasm of the gastrointestinal tract, fundamentally
GISTs and sarcomas. The definitive diagnosis will realize by
histological analysis and inmunochemist of the piece, that will
show focal keratinizations and positivity for the membrane
antigen endothelial, in addition they can show areas of micro-
calcifications and the find of the typical mutation, the translo-
cation (X; 18) SYT/SSX2 (1-3).
The treatment applied till now in these tumors has been the
surgery; Makhlouf et al. shows a series of 10 synovial sarco-
mas, none of them in duodenum, which they resected by seg-
mental sections or atypical gastrectomy and obtained a survival
at four years after 60% (4).
In this series, there has been described a recidiva of 20% to
28 months, which it happened in those more undifferentiated
tumors and of major size.
It seems, according to the scanty published information, that
the forecast of the gastrointestinal sarcoma is in relation with
the size, the location and the differentiation of the tumor. They
will be deeper necessary studies of the patients with this rare
pathology for a better knowledge of the prognosis according to
treatment (1-4).
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Table I. Normal warjers of sinovial sarcoma
Marcker Positivity Characteristics
Vimentine Limited positivity Not in glands
Citoqueratine 8-18 Positive In glandular areas
Citoqueratine PAN Positive In glandular areas
Muscular actine (AML) Negative
S-100 Negative
CD-34 Negative
BCL Positive Granular and diffuse form
C-Kitt/CD-117 Negative
Ki-67 High proliferative activity
